Companies: 10,795·Total market cap: $144.5T

BioLineRx Ltd.

BioLineRx Ltd.

BLRXNASDAQHealthcare● Active

$3.15

$-0.08(-2.48%)

Market Cap$13706775

P/E Ratio—

52W High$6.59

52W Low$2.15

Avg Volume49K

Open$3.19

Beta0.62

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

BioLineRx Ltd.（BLRX）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BLRX · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-2.12Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$1.4MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding4.1MShares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

探索 BioLineRx Ltd. 数据

分析师预测$— · Buy

股息不分红

营收$1.2M-95.89%

盈利EPS $-0.29-141.67%

财务快照

FY 2025Revenue$1.2M▼ 95.89% YoY

202320242025

FY 2025Net Income-$1.2M▲ +87.16% YoY

202320242025

FY 2025EPS$-0.29▼ 141.67% YoY

202320242025

TTM:Revenue: $1.4MNet Income: -$8.9MEPS: $-2.12View income statement →

分析师评级与目标价

Buy7 位分析师

Strong Buy

0

Buy

7

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$3.15Current

$—Avg Target

$—High

合计: 7 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$3.15-2.48%$13.7M #2

Adaptimmune Therapeutics plc

$0.05-3.00%$12.5M #3

$0.05-20.77%$1,665 #4

$2.15+6.15%$9.7M #5

Adlai Nortye Ltd.

$9.71-2.21%$515.4M #6

Apollomics, Inc.

$13.84-4.14%$15.3M

股票表现

1D-4.95%

1W-9.17%

1M+0.00%

3M+15.85%

YTD+10.83%

1Y-48.23%

5Y-97.31%

关于 BioLineRx Ltd.

CEOPhilip A. Serlin

IPO DateJul 27, 2011

Employees28

CountryIL

Websitebiolinerx.com

BioLineRx Ltd. a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatmen…

Biotechnology HealthcareNASDAQADRIL

关于股票概览与关键数据

BioLineRx Ltd.（BLRX）是 Biotechnology 行业的 Healthcare 类公司，于 Jul 27, 2011 在 NASDAQ 上市。截至最近交易日，BLRX 股价为 $3.15，市值约为 $13.7M。过去12个月累计回报 -48.23%，年初至今回报 +10.83%。

根据 7 位华尔街分析师，BioLineRx Ltd. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 BioLineRx Ltd. 营收 $1.2M，净利润 -$1.2M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，BioLineRx Ltd.（BLRX）股价为 $3.15，在 NASDAQ 上市，52周区间为 $2.15 – $6.59。

BLRX 最新股价BLRX quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议